




Finding its rhythm: Startup seeks $4M in funding for trailblazing atrial fibrillation treatment
A new Ottawa biotech startup is seeking to raise $4 million to produce groundbreaking treatments aimed at curing one of the most common heart rhythm






Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
Nominations for 2026 now open.